The online version of this article (doi:10.1186/1758-5996-6-19) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
ST: designed and performed the experiments, analyzed the data and wrote the manuscript; HW and ST: participated in the design of the study; YI: conceived and designed the experiments, and helped to draft the manuscript. All authors read and approved the final manuscript.
The relationship of saliva with plasma protein levels makes saliva an attractive diagnostic tool. Plasma levels of adiponectin and leptin in healthy individuals or diabetes mellitus patients have been previously reported. Nevertheless, salivary levels of these adipocytokines in patients with metabolic syndrome (MS) have never been investigated. This study was aimed to determine adiponectin and leptin levels in saliva and plasma from patients with metabolic syndrome, and evaluate any correlation of these levels with MS.
Forty-six healthy and 82 MS patients were enrolled. Demographic data and blood biochemistries were recorded. Saliva and plasma adiponectin and leptin levels were analyzed by enzyme-linked immunosorbent assay (ELISA).
Adiponectin and leptin were higher in plasma than in saliva (p < .001). Plasma adiponectin was decreased and plasma leptin increased in patients with MS (p < .001). Salivary adiponectin and salivary leptin were not different between healthy subjects and MS patients (p = .619 and p = .523). Correlation between salivary and plasma adiponectin showed significant association (r = .211, p = .018) while salivary and plasma leptin had no correlation (r = -.161, p = .069). Significant correlation was observed between the salivary adiponectin/salivary leptin ratio and plasma adiponectin (r = .371, p < .001), but not with any component of MS. Increased triglyceride and waist circumference were associated with risk of having a low level of plasma adiponectin (OR = 1.009; 95% CI 1.002–1.015 and OR = 1.125; 95% CI 1.029–1.230). For leptin, body mass index and high-density lipoprotein cholesterol (HDL-C) were associated with a high level of plasma leptin (OR = 1.621; 95% CI 1.212–2.168 and OR = .966; 95% CI .938–.996). The OR for MS as predicted by plasma adiponectin was .928 (95% CI .881-.977).
This study showed that salivary adiponectin and leptin do not correlate with MS. Although correlation between salivary and plasma adiponectin was observed, no association with MS was observed. Only plasma adiponectin may be useful for the prediction of MS.
Gavrila D, Salmeron D, Egea-Caparros JM, Huerta JM, Perez-Martinez A, Navarro C, Tormo MJ: Prevalence of metabolic syndrome in murcia region, a Southern European mediterranean area with low cardiovascular risk and high obesity. BMC Public Health. 2011, 11: 562-10.1186/1471-2458-11-562. PubMedCentralCrossRefPubMed
Gronner M, Bosi P, Carvalho A, Casale G, Contrera D, Pereira M, Diogo T: Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study. Braz J Med Biol Res. 2011, 44: 713-719. PubMed
Lohsoonthorn V, Lertmaharit S, Williams M: Prevalence of metabolic syndrome among professional and office workers in Bangkok, Thailand. J Med Assoc Thai. 2007, 90: 1908-1915. PubMed
Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim S-Y, Hamnvik O-PR: Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol. 2011, 301: E567-E584. 10.1152/ajpendo.00315.2011. CrossRef
Özçelik E, Uslu S, Kebapçı N, Kara M, Dokumacıoğlu A, Musmul A: Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome. Diabetes Metab Syndrome: Clin Res Rev. 2010, 4: 13-17. 10.1016/j.dsx.2010.01.005. CrossRef
Jaedicke K: Salivary Adipokine Concentrations in Patients with Type 2 Diabetes. IADR AADR CADR 89th general session and exhibition. 2011, March 16–19
Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644. CrossRefPubMed
Williamson S, Munro C, Pickler R, Grap MJ, Elswick JR: Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Prac. 2012, 1-4. http://dx.doi.org/10.1155/2012/246178,
Wang Z, Zhuo Q, Fu P, Piao J, Tian Y, Xu J, Yang X: Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults?. Diabetes/Metab Res. 2010, 26: 109-114. 10.1002/dmrr.1060. CrossRef
Vega GL, Grundy SM: Metabolic risk susceptibility in Men is partially related to adiponectin/leptin ratio. J Obes. 2013, 2013: 9- CrossRef
Izadi V, Farabad E, Azadbakht L: Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Of Preventive Med. 2013, 4: 133-140.
Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N: Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis. 2011, 10: 79-10.1186/1476-511X-10-79. PubMedCentralCrossRefPubMed
Mojiminiyi O, Abdella N, Arouj M, Nakhi A: Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Inter J Obes. 2007, 31: 213-220. 10.1038/sj.ijo.0803355. CrossRef
Kim SY, Lee SJ, Park HK, Yun JE, Lee M, Sung J, Jee SH: Adiponectin is associated with impaired fasting glucose in the Non-diabetic population. Epidemiol and Health. 2011, 33: e2011007- CrossRef
Webb DR, Khunti K, Chatterjee S, Jarvis J, Davies MJ: Adipocytokine associations with insulin resistance in british South Asians. Exp Diabetes Res. 2013, 2013: 7-
Al-Daghri NM, Al-Attas OS, Sallam R: Adipocytokine profiles as influenced by insulin resistance in obese subjects. Diabetes & Metab Syndr: Clin Res & Rev. 2009, 3: 79-83. 10.1016/j.dsx.2009.02.004. CrossRef
Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M: Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab Syndr and Relat Disord. 2009, 7: 447-452. 10.1089/met.2008.0100. CrossRef
Nakashima R, Yamane K, Kamei N, Nakanishi S, Kohno N: Low serum levels of total and high-molecular-weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest. 2011, 34: 615-619. PubMed
- Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II